Nicox Provides Second Quarter 2022 Financial and Business Highlights
Press Release Nicox Provides Second Quarter 2022 Financial and Business Highlights Enrollment completed in the…
Press Release Nicox Provides Second Quarter 2022 Financial and Business Highlights Enrollment completed in the…
Conference call scheduled for Thursday, July 28, 2022, at 8 AM EDT / 2 PM CET ALLSCHWIL,…
Hyloris Reports Positive Phase 1 Data for HY-004, a proprietary Tranexamic Acid Oral Mouth Rinse…
Internet City, Dubai–(Newsfile Corp. – July 20, 2022) – LBank Exchange, a global digital asset…
TOKYO, Jul 20, 2022 – (JCN Newswire) – Mitsubishi Heavy Industries Engineering, Ltd. (MHIENG), a…
FARNBOROUGH, United Kingdom, Jul 20, 2022 – (JCN Newswire) – Mitsubishi Heavy Industries, Ltd (MHI)…
PETALING JAYA, Malaysia, Jul 20, 2022 – (ACN Newswire) – UCrest Berhad (ACE Market: 0005)…
HONG KONG, Jul 20, 2022 – (ACN Newswire) – Organised by the Hong Kong Trade…
REDWOOD CITY, Calif., July 19, 2022 (GLOBE NEWSWIRE) — Revolution Medicines, Inc. (Nasdaq: RVMD), a…
TOKYO, Jul 20, 2022 – (JCN Newswire) – The LCR Honda CASTROL Team are pleased…
TOKYO, Jul 20, 2022 – (JCN Newswire) – ENEOS Corporation (ENEOS), Suzuki Motor Corporation (Suzuki),…
ADELAIDE, AUS, Jul 20, 2022 – (ACN Newswire) – TrialWire(TM) Technology Platform, the most secure…
NEW YORK, Jul 20, 2022 – (ACN Newswire) – NexBloc today announced that Ankit Sahni…
Field trials have resulted in significant improvement, while leaving minimal footprint TEL AVIV, Israel–(BUSINESS WIRE)–ICL…
TOKYO–(BUSINESS WIRE)–#AI–Renesas Electronics Corporation (TSE:6723), a premier supplier of advanced semiconductor solutions, today announced the…
Itron Engage Provides Partners with Tools, Training and Support for Itron’s Solutions LIBERTY LAKE, Wash.–(BUSINESS…
MILPITAS, Calif.–(BUSINESS WIRE)–SolarEdge Technologies, Inc. (Nasdaq: SEDG), a global leader in smart energy technology, will…
SALT LAKE CITY, July 19, 2022 (GLOBE NEWSWIRE) — Myriad Genetics, Inc., (NASDAQ: MYGN), a…
– Rapid and significant increase in plasma pyrophosphate (PPi) levels observed in all three subjects…
LBS-008 (a/k/a Tinlarebant) is the Company’s orally administered tablet for the treatment of Stargardt disease…